Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Get in-depth and insightful information about the pharmaceutical and medtech industries with pharmaceutical whitepapers from Pharma Intelligence. Covering a range of topics and specialty areas, these informative and authoritative whitepapers present insights and information not found elsewhere.
100+ Total results for product and free and sample content found
Trialtrove: gold standard clinical trials int...
15 Oct 2021
Deep dive into China’s clinical landscape to learn more about the startling growth in clinical research in our whitepaper from Dr Annie Siu, PhD, MBA, APAC - Content Director, Informa Pharma Intelligence and Andrew Benson, MSc - Senior Director, Trialtrove.
TrialScope Disclose
15 Oct 2021
Des changements majeurs arrivent, impactant toutes les étapes des essais cliniques, y compris les essais nouveaux et en cours – êtes-vous prêt ? Sachez à quoi vous attendre et comment maintenir votre conformité en matière de divulgation lorsque le nouveau système d'information sur les essais cliniques (CTIS), créé par l'Agence européenne des médicaments (EMA), entrera en vigueur.
Citeline
28 Sep 2021
In 2017, Informa Pharma Intelligence took a deep dive into the clinical trial landscape in China over the previous 10 years, in a whitepaper entitled “Is China the Dark Horse in Clinical Development?”. That analysis showed that the number of trial starts in China had been trending upwards year-on-year and suggested that China was on course to become a formidable player within the pharma industry on a global stage.
Topic Clinical Trials
Biomedtracker, Datamonitor Healthcare
21 Sep 2021
Against a backdrop of unprecedented disruption, the biopharma and medtech industries reached incredible heights for deal-making activity during 2020.
Topic Drug Review Coronavirus
TrialScope Disclose
14 Sep 2021
Created by the European Medicines Agency (EMA). Stakeholders will use CTIS to: Submit and approve clinical trial applications (CTAs), Submit trial reports, results and notifications, Communicate centrally with the Member States Concerned (MSC) in the clinical trial
Topic Policy & Regulation Clinical Trials Clinical Trials Blog
Pharmaprojects, Citeline
By Ian Lloyd 13 Aug 2021
Our world was disrupted at warp speed during 2020. Are you ready to gain a deeper understanding of the year that changed our perceptions of possible?
Citeline Study Feasibility
29 Jul 2021
This informative whitepaper introduces you to best practices in study feasibility, which laid the groundwork for our new predictive analytic that is launching soon, Citeline Study Feasibility. Our industry-leading technology will deliver advanced insight to improve your clinical trial decisions, fast-track enrollment and optimize cycle times – all with less effort.
Topic Clinical Trials
28 Jun 2021
Study feasibility is a fundamental contributor to the overall success of a clinical development program. However, selecting the right countries, sites and investigators and starting up as quickly as possible remains a challenge, leading to greatly variable performance and inaccurate predictions for important trial milestones.
Topic Clinical Trials
Citeline, Trialtrove
20 May 2021
Over the past five years, our analysis of completed trials consistently observed growth trends.
Topic Coronavirus Clinical Trials
No Records Found
Request a live demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Client Services
Contact us for product technical and account support.
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
